Azenta to participate in the 25th Annual Needham Growth Conference
Get Alerts AZTA Hot Sheet
Join SI Premium – FREE
BURLINGTON, Mass., Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 25th Annual Needham Growth Conference in New York, NY, on Wednesday, January 11, 2023, which includes a presentation beginning at 11:00 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.
Azenta is headquartered in Massachusetts, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACTS:Sara SilvermanHead of Investor Relations978.262.2635[email protected]
Sherry Dinsmore978.262.2400[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-25th-annual-needham-growth-conference-301714226.html
SOURCE Azenta
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Skydog Sanctuary Demands Immediate Shutdown of Federal Wild Horse Sales Program After NY Times Confirms Slaughter Pipeline
- Webinar: The Storytelling Skill Professionals Can't Skip Before Prompting AI
- In HelloNation, Insurance Expert Daniel C. DiCocco Details Factors that Impact Insurance Premiums
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share